Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.010 | 1.010 | 0.000 |
Stocks | 98.990 | 98.990 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.974 | 21.717 |
Price to Book | 3.207 | 4.007 |
Price to Sales | 2.621 | 2.277 |
Price to Cash Flow | 16.439 | 16.973 |
Dividend Yield | 1.713 | 1.339 |
5 Years Earnings Growth | 9.008 | 11.138 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.920 | 94.963 |
Consumer Cyclical | 1.080 | 8.071 |
Number of long holdings: 48
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.60 | 886.6 | +2.28% | |
Eli Lilly and Co | - | 4.35 | - | - | |
Merck & Co Inc | - | 4.10 | - | - | |
Amgen Inc | - | 3.53 | - | - | |
Stryker Corp | - | 3.11 | - | - | |
HCA Healthcare Inc | - | 2.90 | - | - | |
Thermo Fisher Scientific Inc | - | 2.89 | - | - | |
Vertex Pharmaceuticals Inc | - | 2.86 | - | - | |
Edwards Lifesciences Corp | - | 2.79 | - | - | |
Boston Scientific Corp | - | 2.76 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -3.44 | - | ||
FIM Emerging markets ESG | 385.95M | 0.28 | -1.75 | 4.89 | ||
S SaastOrahasto Kohtuullinen | 283.28M | 5.46 | 4.08 | 6.13 | ||
FIM USA | 245.85M | 14.43 | 12.95 | 13.14 | ||
S-Saastorahasto Rohkea | 243.2M | 8.00 | 7.09 | 8.71 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review